The AR-mediated regulation of LAT1 and ASCT2 is of clinical importance as inhibition of these transporters hampers prostate tumour growth35,95 and their increased expression provides opportunities for non-invasive diagnostic imaging and disease monitoring in patients with prostate cancer. Here, SLC1A5 is linked to prostate carcinoma.